BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16984566)

  • 1. Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.
    Aoki H; Ishidoya S; Ito A; Endoh M; Shimazui T; Arai Y
    Int J Urol; 2006 Sep; 13(9):1254-8. PubMed ID: 16984566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report.
    Hoshi S; Ohyama C; Ono K; Takeda A; Yamashita S; Yamato T; Itoh A; Satoh M; Saito S; Okada Y; Sohma F; Arai Y
    Int J Clin Oncol; 2004 Apr; 9(2):125-9. PubMed ID: 15108045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
    Chiappori A; Simon G; Williams C; Haura E; Rocha-Lima C; Wagner H; Bepler G; Antonia S
    Oncology; 2005; 68(4-6):382-90. PubMed ID: 16020967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Pectasides D; Aspropotamitis A; Halikia A; Visvikis A; Antoniou F; Kalantaridou A; Karvounis N; Batzios S; Athanassiou A
    J Clin Oncol; 1999 Dec; 17(12):3816-21. PubMed ID: 10577854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].
    Ito K; Adachi S; Iijima T; Nakatsuji Y; Kimura T; Nobunaga T
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):141-4. PubMed ID: 12557720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer.
    Karapanagiotou EM; Charpidou A; Tzannou I; Dilana K; Kotteas E; Tourkantonis I; Kosmas E; Provata A; Syrigos K
    Med Oncol; 2008; 25(3):303-8. PubMed ID: 18204976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with Gemcitabine and Cisplatin for Advanced Ductal Adenocarcinoma of the Prostate: Clinical Courses of Two Patients.
    Kamiyama Y; Mitsuzuka K; Watanabe M; Kawamorita N; Yamada S; Kaiho Y; Ito A; Nakagawa H; Arai Y
    Tohoku J Exp Med; 2015 Dec; 237(4):317-21. PubMed ID: 26633178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
    Skarlos DV; Dimopoulos AM; Kosmidis P; Papakostas P; Pavlidis N; Bacoyiannis C; Kiamouris C; Klouvas G; Gogas H; Fountzilas G; Samantas E;
    Lung Cancer; 2003 Jul; 41(1):107-11. PubMed ID: 12826319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of small cell carcinoma of the prostate and review of the literature.
    Addeo A; Rinaldi C; Panades M
    Tumori; 2012; 98(3):76e-78e. PubMed ID: 22825523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.
    Yoneyama T; Imai A; Hatakeyama S; Hashimoto Y; Koie T; Ohyama C
    Int J Clin Oncol; 2015 Dec; 20(6):1179-84. PubMed ID: 26007690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
    Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SMALL CELL CARCINOMA OF THE PROSTATE: A CASE REPORT OF RELATIVE LONG-TERM SURVIVAL].
    Hirai M; Konishi T; Saito K; Washino S; Kobayashi Y; Nokubi M; Miyagawa T
    Nihon Hinyokika Gakkai Zasshi; 2015 Oct; 106(4):280-4. PubMed ID: 26717788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
    Zhu J; Sharma DB; Chen AB; Johnson BE; Weeks JC; Schrag D
    Cancer; 2013 Jun; 119(11):2048-60. PubMed ID: 23564469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy consisting of gemcitabine, docetaxel and carboplatin as a second-line chemotherapy for patients with MVAC-treated metastatic urothelial carcinoma].
    Inoue T; Obara T; Saito M; Kumazawa T; Narita S; Horikawa Y; Yuasa T; Tsuchiya N; Satoh S; Habuchi T
    Hinyokika Kiyo; 2008 Sep; 54(9):581-5. PubMed ID: 18975570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial.
    Garcia JA; Hutson TE; Shepard D; Elson P; Dreicer R
    Cancer; 2011 Feb; 117(4):752-7. PubMed ID: 20922803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
    Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR
    Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.
    Vasey PA; Atkinson R; Osborne R; Parkin D; Symonds R; Paul J; Lewsley L; Coleman R; Reed NS; Kaye S; Rustin GJ
    Br J Cancer; 2006 Jan; 94(1):62-8. PubMed ID: 16404361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.
    Bepler G; Williams C; Schell MJ; Chen W; Zheng Z; Simon G; Gadgeel S; Zhao X; Schreiber F; Brahmer J; Chiappori A; Tanvetyanon T; Pinder-Schenck M; Gray J; Haura E; Antonia S; Fischer JR
    J Clin Oncol; 2013 Jul; 31(19):2404-12. PubMed ID: 23690416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Docetaxel for small cell carcinoma of the prostate with a metastatic pelvic tumor: a case report].
    Ishii G; Omono H; Kasai K; Hata K; Kimura T; Suzuki M; Egawa S
    Hinyokika Kiyo; 2014 Dec; 60(12):641-4. PubMed ID: 25602482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
    Fidias PM; Dakhil SR; Lyss AP; Loesch DM; Waterhouse DM; Bromund JL; Chen R; Hristova-Kazmierski M; Treat J; Obasaju CK; Marciniak M; Gill J; Schiller JH
    J Clin Oncol; 2009 Feb; 27(4):591-8. PubMed ID: 19075278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.